Year: 2023
Type: article
Abstract: The Society for Melanoma Research (SMR) was created 20 years ago and has unequivocally contributed to the vast progress of the field, particularly for the treatment of melanoma patients with metastatic disease by facilitating synergistic collaborations between clinicians, researchers at the bench, and industry. In commemoration of the 20th anniversary of the first SMR International Congress (held in 2003 in Philadelphia), we look to the future by highlighting the perspectives of the next generation of rising stars, medical, and graduate students across six continents.
Source: Pigment Cell & Melanoma Research
DOI: 10.1111/pcmr.13136
Institutions: Lankenau Institute for Medical Research, The Wistar Institute, University of Pennsylvania, Johns Hopkins University, Northeast Ohio Medical University, Shanghai Jiao Tong University, QIMR Berghofer Medical Research Institute, Universidade de São Paulo, University of Cape Town, Danish Cancer Society
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,530
Funder: National Cancer Institute
OpenAlex ID: W4387527044